Zeyu Wang
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Genetics top 2%
- Glioma Diagnosis and Treatment
Papers in
- Immunology 57
- Immune cells in cancer 37
- Immune Cell Function and Interaction 10
- Immunotherapy and Immune Responses 10
-
- Ferroptosis and cancer prognosis 39
- Co-authors
- Quan Cheng (61 shared papers)Hao Zhang (58 shared papers)Ziyu Dai (53 shared papers)Zhixiong Liu (27 shared papers)Wantao Wu (26 shared papers)Nan Zhang (28 shared papers)Liyang Zhang (22 shared papers)Wenjing Zeng (4 shared papers)
- Journals
- Frontiers in Immunology (22 papers)Frontiers in Cell and Developmental Biology (5 papers)Frontiers in Oncology (5 papers)Ocean & Coastal Management (4 papers)Biomedicine & Pharmacotherapy (3 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Zeyu Wang
149 papers receiving 3.4k citations
Hit Papers
Peers
Comparison fields: 5 of 156
- Cancer Research 811
- Genetics 564
- Immunology 945
- Oncology 877
- Pulmonary and Respiratory Medicine 869
Countries citing papers authored by Zeyu Wang
This map shows the geographic impact of Zeyu Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zeyu Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zeyu Wang more than expected).
Fields of papers citing papers by Zeyu Wang
This network shows the impact of papers produced by Zeyu Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zeyu Wang. The network helps show where Zeyu Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Zeyu Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 156 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Glioma targeted therapy: insight into future of molecular approaches Hit paper breakdown → | 2022 | 458 |
| 2 | Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer Hit paper breakdown → | 2021 | 372 |
| 3 | Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts Hit paper breakdown → | 2022 | 174 |
| 4 | 2021 | 109 | |
| 5 | 2022 | 89 | |
| 6 | 2021 | 88 | |
| 7 | 2022 | 66 | |
| 8 | 2019 | 64 | |
| 9 | 2021 | 64 | |
| 10 | 2019 | 59 | |
| 11 | 2023 | 51 | |
| 12 | 2023 | 46 | |
| 13 | 2020 | 46 | |
| 14 | 2022 | 44 | |
| 15 | 2023 | 43 | |
| 16 | 2021 | 43 | |
| 17 | 2021 | 42 | |
| 18 | 2021 | 41 | |
| 19 | 2021 | 40 | |
| 20 | 2019 | 38 |
About Zeyu Wang
Zeyu Wang is a scholar working on Immunology, Pulmonary and Respiratory Medicine, Molecular Biology, Oncology and Cancer Research, having authored 156 papers that have together received 3.5k indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (39 papers), Immune cells in cancer (37 papers), Cancer Immunotherapy and Biomarkers (20 papers), Glioma Diagnosis and Treatment (20 papers), Cancer-related molecular mechanisms research (15 papers), Immune Cell Function and Interaction (10 papers), Immunotherapy and Immune Responses (10 papers) and RNA modifications and cancer (8 papers). The work is most often cited by research in Cancer Research (811 citations), Genetics (564 citations), Immunology (945 citations), Oncology (877 citations) and Pulmonary and Respiratory Medicine (869 citations). Zeyu Wang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Quan Cheng, Hao Zhang, Ziyu Dai, Zhixiong Liu, Wantao Wu, Nan Zhang, Liyang Zhang, Wenjing Zeng, Xun Zhang and Peng Luo. Their work appears in journals such as Frontiers in Immunology, Frontiers in Cell and Developmental Biology, Frontiers in Oncology, Ocean & Coastal Management and Biomedicine & Pharmacotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.